001491224 000__ 04771nam\\2200505Mu\4500
001491224 001__ 1491224
001491224 003__ NhCcYBP
001491224 005__ 20240410003232.0
001491224 006__ m\\\\\o\\d\\\\\\\\
001491224 007__ cr\cn\nnnunnun
001491224 008__ 230923s2023\\\\xx\\\\\\o\\\\\|||\0\eng\d
001491224 020__ $$a9781000958447
001491224 020__ $$a1000958442
001491224 040__ $$aNhCcYBP$$cNhCcYBP
001491224 050_4 $$aRA644.C67$$bI584 2024
001491224 08204 $$a362.1962414
001491224 1001_ $$aQidwai, M. Tabish.
001491224 24510 $$aInteraction of Coronavirus Disease 2019 with other infectious and systemic diseases.
001491224 260__ $$aMilton :$$bTaylor & Francis Group,$$c2023.
001491224 300__ $$a1 online resource (215 pages)
001491224 336__ $$atext$$btxt$$2rdacontent
001491224 337__ $$acomputer$$bc$$2rdamedia
001491224 338__ $$aonline resource$$bcr$$2rdacarrier
001491224 500__ $$a6.6 Major Association of COVID-19 and PD
001491224 504__ $$aReferences -- Chapter 2 Investigation of Post-COVID/Long COVID Complications in Humans -- 2.1 Introduction -- 2.2 Pathophysiology -- 2.3 Respiratory Complications -- 2.4 Cardiovascular Complexities -- 2.5 Haematological Abnormalities -- 2.6 Neurological Complications -- 2.7 Dermatological Sequelae -- 2.8 Diabetes-Related Comorbidities -- 2.9 Renal Complications -- 2.10 Gastrointestinal Sequelae -- 2.11 Conclusion -- References -- Part II SARS CoV-2 Co-Infection with Other Pathogens -- Chapter 3 Falciparum Malaria and COVID-19 Co-Infections -- 3.1 Introduction
001491224 5050_ $$aCover -- Half Title -- Title -- Copyright -- Contents -- List of Contributors -- Part I Current Trends in Pathophysiology and Post-COVID Effects -- Chapter 1 Pathophysiology of SARS-CoV-2 -- 1.1 Introduction -- 1.2 Structure of the Virus -- 1.3 Entry of SARS-CoV-2 -- 1.4 Entry Factors of SARS-CoV2 -- 1.5 Hallmark of COVID-19 -- 1.5.1 Pathophysiology of SARS-CoV-2 -- 1.6 Affecting Respiratory Tract -- 1.7 SARS-CoV-2 Infection Affects RAAS -- 1.8 Endothelial Dysfunction and Platelet Activation -- 1.9 Endocrine Dysfunction -- 1.9.1 Neuropathology -- 1.10 List of Abbreviations -- Acknowledgement
001491224 5058_ $$a3.2 Interactions Between SARS-CoV-2 Infection and Malaria -- 3.3 Similarity of Malaria and COVID-19 Symptoms and Problems Associated with It -- 3.4 Potential Effects of Previous Malaria Exposure on Clinical Profiles and Outcomes in Patients with SARS-CoV-2 Infection -- 3.5 Important Clinical Correlations of Co-Infection in High Malaria Burden Areas -- 3.6 Conclusion -- References -- Chapter 4 Interaction of COVID-19 and Tuberculosis -- 4.1 Introduction -- 4.2 Epidemiological and Clinical Presentation of COVID-19 with TB Infection -- 4.3 Biological Mechanism of COVID-19 and TB
001491224 5058_ $$a4.4 Diagnostic Approaches for COVID-19 and Tuberculosis -- 4.4.1 Diagnostic Approaches for COVID-19 -- 4.4.2 Smear Microscopy using Ziehl Neelsen (ZN) Staining Method -- 4.5 Impact of COVID-19 on TB -- 4.6 Conclusion -- References -- Chapter 5 Coinfection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections -- 5.1 Introduction -- 5.2 Respiratory Viral Co-Infection in COVID-19 -- 5.2.1 Co-Infection of SARS-CoV-2 with Influenza Virus -- 5.2.2 Co-Infection of SARS-CoV-2 with Human Coronavirus (CoVs) -- 5.2.3 Co-Infection of SARS-CoV-2 with Adenovirus
001491224 5058_ $$a5.3 Systemic Viral Co-Infection in COVID-19 -- 5.3.1 SARS-CoV-2 and HIV Co-Infections -- 5.3.2 SARS-CoV-2 and CMV Co-Infections -- 5.3.3 SARS-CoV-2 and EBV Co-Infections -- 5.3.4 SARS-CoV-2 and HBV Co-Infections -- 5.4 Viral Co-infections: Symptoms and Diagnosis -- 5.5 Conclusion -- References -- Part III COVID-19 and Neurological Complications -- Chapter 6 Neurological Association of COVID-19 and Neurodegenerative Disorders -- 6.1 Introduction -- 6.2 COVID-19 and Neurodegenerative Diseases -- 6.3 COVID-19 and AD -- 6.4 COVID-19 and PD -- 6.5 COVID-19 and MS
001491224 506__ $$aAccess limited to authorized users
001491224 533__ $$aElectronic reproduction.$$bAnn Arbor, MI$$nAvailable via World Wide Web.
001491224 588__ $$aDescription based on print version record.
001491224 650_0 $$aCOVID-19 (Disease)$$xComplications.
001491224 650_0 $$aCOVID-19 (Disease)$$xPathogenesis.
001491224 650_0 $$aCoronavirus infections.
001491224 655_0 $$aElectronic books
001491224 7102_ $$aProQuest (Firm)
001491224 77608 $$iPrint version:$$aQidwai, M. Tabish$$tInteraction of Coronavirus Disease 2019 with Other Infectious and Systemic Diseases$$dMilton : Taylor & Francis Group,c2023$$z9781032350233
001491224 852__ $$bebk
001491224 85640 $$3GOBI DDA$$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=30736019$$zOnline Access
001491224 909CO $$ooai:library.usi.edu:1491224$$pGLOBAL_SET
001491224 980__ $$aBIB
001491224 980__ $$aEBOOK
001491224 982__ $$aEbook
001491224 983__ $$aOnline